Lasa Supergenerics (BOM:540702) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540702 Lasa Supergenerics Ltd BOM:540702
39 GF Score
Price ₹7.32
GF Value ₹4.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lasa Supergenerics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Lasa Supergenerics Valuation Rank Related Terms

BOM:540702
39GF Score
Lasa Supergenerics Ltd BOM:540702
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lasa Supergenerics (BOM:540702) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹7.32 is trading 69.4% above its estimated GF Value™ of ₹4.32. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for BOM:540702:

  • Valuation Rank:
  • GF Value™: ₹4.32 vs. price of ₹7.32 (69.4% above fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the BOM:540702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lasa Supergenerics Business Description

Other Exchanges LASA:India
Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
39GF Score

Get the complete analysis for BOM:540702

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.32
Price
₹4.32
GF Value